Real-world insights into cardiometabolic comorbidities and their role in triple-negative breast cancer outcomes. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Triple negative breast cancer (TNBC) represents approximately 10-15% of all breast cancer diagnoses but accounts for a disproportionately high percentage of breast cancer deaths. What sets this ...
Researchers developed a tool to predict chemotherapy response for patients with triple-negative breast cancer. Researchers at The University of Texas MD Anderson Cancer Center have developed a new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results